The International Testing Agency (ITA), mandated by the Olympic Council of Asia (OCA) to independently handle areas of the anti-doping program at the Asian Games Hangzhou 2022, including results management, reports that a sample collected from kabbadi athlete Adil Hussain from Pakistan has returned an Adverse Analytical Finding¹ for 19-norandrosterone, a non-specified Prohibited Substance, according to the Prohibited List of the World Anti-Doping Agency (WADA).
The sample was collected by the ITA at the Asian Games Hangzhou 2022 during an in-competition anti-doping control performed on 4 October 2023. The Sample Collection Authority was the China Anti-Doping Agency.
The athlete has been informed of the case. He has the right to request the analysis of the B-samples.
The matter will thereafter be referred to the Anti-Doping Division of the Court of Arbitration for Sport (CAS ADD) for adjudication under the OCA Anti-Doping Rules.
Given that the case is underway, there will be no further comments during the ongoing proceeding.
List of Anti-Doping Rule Violations at the Asian Games Hangzhou 2022
The International Testing Agency (ITA), mandated by the Olympic Council of Asia (OCA) to independently handle areas of the anti-doping program at the Asian Games Hangzhou 2022, including results management, reports that a sample collected from track and field athlete Wesam Nasser A ALFARSI, from Saudi Arabia, has returned an Adverse Analytical Finding¹ for the non-specified prohibited substance darbepoetin (dEPO) according to the Prohibited List of the World Anti-Doping Agency (WADA).
The sample was collected by the ITA at the Asian Games Hangzhou 2022 during an out-of-competition anti-doping control performed on 29 September 2023.
The Sample Collection Authority was the China Anti-Doping Agency.
The athlete has been informed of the case and has been provisionally suspended with immediate effect. He has the right to request the analysis of the B-sample.
The matter will thereafter be referred to the Anti-Doping Division of the Court of Arbitration for Sport (CAS ADD) for adjudication under the OCA Anti-Doping Rules.
Given that the case is underway, there will be no further comments during the ongoing proceeding.
The International Testing Agency (ITA), mandated by the Olympic Counsel of Asia (OCA) to independently handle areas of the anti-doping program at the Asian Games Hangzhou 2022, including results management, reports that a sample collected from boxing athlete Mohammad Khaibar Nooristani (Afghanistan) has returned an Adverse Analytical Finding¹ for the non-specified prohibited substances (i) 19-norandrosterone and (ii) Clostebol metabolite 4-chloro-3α-hydroxy-androst-4-en-17-one according to the Prohibited List of the World Anti-Doping Agency (WADA).
The sample was collected by the ITA at the Asian Games Hangzhou 2022 during an out-of-competition anti-doping control performed on 21 September 2023.
The athlete has been informed of the case and has been provisionally suspended with immediate effect. He has the right to request the analysis of the B-sample.
The matter will thereafter be referred to the Anti-Doping Division of the Court of Arbitration for Sport (CAS ADD) for adjudication under the OCA Anti-Doping Rules.
Given that the case is underway, there will be no further comments during the ongoing proceeding.
Global Summit 2024